Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grastek for Birch Pollen Induced Allergic Rhinitis
NCT02394600Phase 4Completed
- Sponsor
- Queen's University
- Start
- Apr 2015
- Primary completion
- Apr 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of SQ SLIT-tablet in Birch pollen-induced allergic rhinoconjunctivitis, sponsored by Queen's University. Started Apr 2015; status: completed.
02
Drugs
SQ SLIT-tablet
03
Conditions
Birch pollen-induced allergic rhinoconjunctivitis
Beyond the preview
Go deeper on NCT02394600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02394600.